Our results collectively demonstrate that the PTEN/Akt/NF-κB axis plays a pivotal role in regulating YY1 via HIF-1α, and this mechanism contributes to Gp-170-mediated chemoresistance in pediatric ALL. The gene discussed is HIF1A; the disease is acute lymphoblastic leukemia.